Clinical trials
Phase 2 Lung Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Upstream Bio Inc. | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| Altair Therapeutics, Inc. | 1 |
| Celgene | 1 |
| Eli Lilly and Company | 1 |
| Iovance Biotherapeutics, Inc. | 1 |
| Mereo BioPharma | 1 |
| Pulmovant, Inc. | 1 |
| Revolution Medicines, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 17 |
| Respiratory Tract Diseases | 8 |
| Asthma | 5 |
| Bronchial Diseases | 4 |
| Carcinoma | 4 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Lung Neoplasms | 4 |
| Emphysema | 3 |
| Fibrosis | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.